Breast Cancer



Journal of Cancer Immunology and therapy is a peer-reviewed journal publishes outstanding original articles reporting major advances in cancer immunology and immunotherapy that span the discipline from basic investigations in host-tumour interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials.

Breast cancer is one of the most common cancers among women, accounting for 25% (1.7 million) of new cases and 15% of cancer deaths. Breast cancer has attracted growing attention among researchers and academic circles.

A highly effective research approach for breast cancer is to create animal models of breast cancer. Among the proposed models, the transgenic mice or GEM model is seemingly the best choice for providing specificity and possibility for development of various tumors, while the chemically induced models offer higher cost-effectiveness and greater ease of application. Nonetheless, these models are not only incapable of providing specificity, but also have the potential for developing other tumors in other tissues as well as heterogenic tumors in mammary tissues. It is thus a specifically ineffective technique for studying tumor cells. Although there are many different techniques for inducing breast cancer, what is in fact required is the quantitative and qualitative development of effective and reliable techniques.

We invite all type of articles related to new concepts and advances in basic Cancer Discovery, Cancer Epidemiology, Biomarkers & Prevention, Cancer Immunology Research, Cancer Surgery, Advances in Cancer Prevention, Breast Cancer, Cancer Biology, Cancer Treatment, Cancer Management and Research, Integrative Cancer Therapies, Clinical cancer immunology and therapy. Journal Accepts all kinds of original research articles, systematic reviews, short note communications, case reports, Editorials, letters to the Editors and expert opinions & commentaries from different regions for publication.

Authors can submit their manuscripts as an email attachment to the following e-mail id: 

Shelley Brown
Editorial Team
Journal of Cancer Immunology and Therapy
Whats App: +1-947-333-4405